Search for other papers by R. Paschke in
Google Scholar
PubMed
Search for other papers by M. Niedziela in
Google Scholar
PubMed
Search for other papers by B. Vaidya in
Google Scholar
PubMed
Search for other papers by L. Persani in
Google Scholar
PubMed
Search for other papers by B. Rapoport in
Google Scholar
PubMed
Search for other papers by J. Leclere in
Google Scholar
PubMed
Introduction Familial non-autoimmune autosomal dominant hyperthyroidism (FNAH) and persistent sporadic congenital non-autoimmune hyperthyroidism (PSNAH) are rare forms of hyperthyroidism caused by germline mutations in the thyroid
Search for other papers by R. Elisei in
Google Scholar
PubMed
Search for other papers by M. Alevizaki in
Google Scholar
PubMed
Search for other papers by B. Conte-Devolx in
Google Scholar
PubMed
Search for other papers by K. Frank-Raue in
Google Scholar
PubMed
Search for other papers by V. Leite in
Google Scholar
PubMed
Search for other papers by G.R. Williams in
Google Scholar
PubMed
determine possible development of PHEO or PHPT, and the need for early counseling and genetic screening of relatives. Recommendation 5 (a) All patients with either apparently sporadic or familial MTC should be screened for germline RET mutations (QOE
Search for other papers by Thomas Karrasch in
Google Scholar
PubMed
Search for other papers by Saskia M. Herbst in
Google Scholar
PubMed
Search for other papers by Ute Hehr in
Google Scholar
PubMed
Search for other papers by Andreas Schmid in
Google Scholar
PubMed
Search for other papers by Andreas Schäffler in
Google Scholar
PubMed
What Is Known about This Topic? • The pathogenic effect of the p.Val804Met missense mutation of the RET proto-oncogene is well described in familial medullary thyroid cancer. In contrast, the clinical significance of the novel missense
Search for other papers by Patrice Rodien in
Google Scholar
PubMed
disease or the condition on which the development group will focus largely determines the way some of the key points can be achieved. The scope, here, is the familial and sporadic non- autoimmune hyperthyroidism caused by TSH receptor germline mutations
Search for other papers by Grace Segall in
Google Scholar
PubMed
Search for other papers by Ravinder Singh in
Google Scholar
PubMed
Search for other papers by Min-Hua Jen in
Google Scholar
PubMed
Search for other papers by Isaac Sanderson in
Google Scholar
PubMed
Search for other papers by Alex Rider in
Google Scholar
PubMed
Search for other papers by Katie Lewis in
Google Scholar
PubMed
Search for other papers by Urpo Kiiskinen in
Google Scholar
PubMed
-cancer-related deaths ( 6 ). Approximately 75% of MTC cases are sporadic, and 25% are hereditary ( 7 , 8 ). The hereditary form of MTC can occur either with other endocrine neoplasms (multiple endocrine neoplasia (MEN) types 2A and 2B) or alone (familial MTC) ( 7 , 8
Search for other papers by Dorothée Bouron-Dal Soglio in
Google Scholar
PubMed
Department of Human Genetics, McGill University, Montreal, Québec, Canada
Search for other papers by Leanne de Kock in
Google Scholar
PubMed
Search for other papers by Richard Gauci in
Google Scholar
PubMed
Search for other papers by Nelly Sabbaghian in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, Princess Margaret Hospital for Children, Subiaco, Washington, Australia
Search for other papers by Elizabeth Thomas in
Google Scholar
PubMed
Search for other papers by Helen C. Atkinson in
Google Scholar
PubMed
King Edward Memorial Hospital, Perth, Washington, Australia
Search for other papers by Nicholas Pachter in
Google Scholar
PubMed
Search for other papers by Simon Ryan in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Washington, Australia
Search for other papers by John P. Walsh in
Google Scholar
PubMed
Search for other papers by M. Priyanthi Kumarasinghe in
Google Scholar
PubMed
Search for other papers by Karen Carpenter in
Google Scholar
PubMed
Search for other papers by Ayça Aydoğan in
Google Scholar
PubMed
Search for other papers by Colin J.R. Stewart in
Google Scholar
PubMed
Department of Human Genetics, McGill University, Montreal, Québec, Canada
Department of Medical Genetics,
Search for other papers by William D. Foulkes in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, School
Search for other papers by Catherine S. Choong in
Google Scholar
PubMed
What Is Known about This Topic? Clinicians should be suspicious of an underlying genetic aetiology when a child or adolescent presents with nodular thyroid disease and a history of familial malignancy or syndrome-related diseases. Targeted
Search for other papers by Chantal A Lebbink in
Google Scholar
PubMed
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Agnieszka Czarniecka in
Google Scholar
PubMed
Search for other papers by Renuka P Dias in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Louise Izatt in
Google Scholar
PubMed
Search for other papers by Heiko Krude in
Google Scholar
PubMed
Search for other papers by Kerstin Lorenz in
Google Scholar
PubMed
Search for other papers by Markus Luster in
Google Scholar
PubMed
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Search for other papers by Arnoldo Piccardo in
Google Scholar
PubMed
Search for other papers by Manuel Sobrinho-Simões in
Google Scholar
PubMed
Search for other papers by Toru Takano in
Google Scholar
PubMed
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
Search for other papers by Frederik A Verburg in
Google Scholar
PubMed
Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed
for developing DTC We recommend that patients with a high risk of developing DTC (history of radiation exposure to the thyroid or a thyroid cancer predisposition syndromes) should be counseled for surveillance (4S). We suggest that initiation of
London School of Hygiene and Tropical Medicine, London
Search for other papers by Peter N. Taylor in
Google Scholar
PubMed
Search for other papers by Bijay Vaidya in
Google Scholar
PubMed
ago as 1972 [ 22 ]. Whilst aplasia cutis can be familial or occur spontaneously, it is rare in babies not exposed to teratogens, with a birth prevalence of 0.03% [ 23 ]. In keeping with this, there was circumstantial evidence of an association between
Search for other papers by Christiaan F Mooij in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK
Search for other papers by Timothy D Cheetham in
Google Scholar
PubMed
Search for other papers by Frederik A Verburg in
Google Scholar
PubMed
Search for other papers by Anja Eckstein in
Google Scholar
PubMed
Endocrine Unit, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK
Search for other papers by Simon H Pearce in
Google Scholar
PubMed
Search for other papers by Juliane Léger in
Google Scholar
PubMed
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
usually transient. Serious side-effects that warrant stopping ATD are rare (2–3 per 100,000) (1,ØØØO). • Patients and families should be counseled about ATD side effects and the criteria for stopping the drug and seeking health professional guidance (1
Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria, Modena, Italy
Search for other papers by Giulia Brigante in
Google Scholar
PubMed
Search for other papers by Clara Lazzaretti in
Google Scholar
PubMed
Search for other papers by Elia Paradiso in
Google Scholar
PubMed
Search for other papers by Federico Nuzzo in
Google Scholar
PubMed
Search for other papers by Martina Sitti in
Google Scholar
PubMed
Search for other papers by Frank Tüttelmann in
Google Scholar
PubMed
Search for other papers by Gabriele Moretti in
Google Scholar
PubMed
Search for other papers by Roberto Silvestri in
Google Scholar
PubMed
Search for other papers by Federica Gemignani in
Google Scholar
PubMed
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany
Search for other papers by Asta Försti in
Google Scholar
PubMed
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Search for other papers by Kari Hemminki in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Cristina Romei in
Google Scholar
PubMed
Search for other papers by Eric Adriano Zizzi in
Google Scholar
PubMed
Search for other papers by Marco Agostino Deriu in
Google Scholar
PubMed
Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria, Modena, Italy
Center for Genomic Research, University of Modena and Reggio Emilia, Modena, Italy
Search for other papers by Manuela Simoni in
Google Scholar
PubMed
Search for other papers by Stefano Landi in
Google Scholar
PubMed
Center for Genomic Research, University of Modena and Reggio Emilia, Modena, Italy
Search for other papers by Livio Casarini in
Google Scholar
PubMed
five Nordic countries . Journal of Medical Genetics 2013 50 373 – 382 . ( https://doi.org/10.1136/jmedgenet-2012-101412 ) 6 Hemminki K Sundquist J Lorenzo Bermejo J . Familial risks for cancer as the basis for evidence-based clinical referral